Bisoprolol Fumarate

DRUG4 trials

Sponsors

Fakultni Nemocnice Ostrava, Peking Union Medical College Hospital, Université de Sherbrooke, Damanhour University

Conditions

Acute Coronary SyndromeCardiomyopathy, DilatedChronic heart failure with reduced ejection fractionDuchenne Muscular DystrophyType 2 Diabetes

Phase 2

Bisoprolol in DMD Early Cardiomyopathy

Peking Union Medical College HospitalCardiomyopathy, Dilated, Duchenne Muscular Dystrophy

Start: 2019-01-16End: 2024-07-01Target: 42Updated: 2022-09-28

Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome

CompletedNCT05536271

Damanhour UniversityAcute Coronary Syndrome

Start: 2021-09-01End: 2022-08-16Updated: 2023-06-07

Phase 4

Use of determination of drug levels to optimize pharmacotherapy of heart failure

RecruitingCTIS2023-506283-13-00

Fakultni Nemocnice OstravaChronic heart failure with reduced ejection fraction

Start: 2024-04-09Target: 100Updated: 2024-03-12

Unknown Phase

Activation of Brown Adipose Tissue Metabolism Using Mirabegron

CompletedNCT04823442

Université de SherbrookeType 2 Diabetes

Start: 2021-01-21End: 2022-04-04Updated: 2024-12-09

Related Papers

The effects of the β<sub>1</sub>‐adrenergic receptor antagonist bisoprolol administration on mirabegron‐stimulated human brown adipose tissue thermogenesis

Acta Physiologica2024-03-193 citations